Stone, J. K.
Mehta, N. A.
Singh, H.
El-Matary, W.
Bernstein, C. N.
Article History
Received: 23 January 2023
Accepted: 18 April 2023
First Online: 29 April 2023
Declarations
:
: Dr. Stone has provided consulting for Boston Scientific. Dr. Mehta has no conflicts to disclose. Dr. Singh has been on advisory boards or consulted to Pendopharm, Amgen Canada, Roche Canada, Sandoz Canada, Takeda Canada, Bristol Myers Squibb and Guardant Health, Inc. and has received research funding for investigator initiated study from Pfizer. Dr El-Matary has consulted to Abbvie, Janssen, Merck Pharmaceuticals, has received speaker fees from Abbvie and had investigator-initiated research support from Janssen. Dr. Bernstein is supported by the Bingham Chair in Gastroenterology. Dr. Bernstein has served on advisory Boards for AbbVie Canada, Amgen Canada, Bristol Myers Squibb Canada, JAMP Pharmaceuticals, Roche Canada, Janssen Canada, Sandoz Canada, Takeda Canada, and Pfizer Canada; Consultant for Mylan Pharmaceuticals and Takeda; Educational grants from Abbvie Canada, Pfizer Canada, Takeda Canada, Bristol Myers Squibb Canada, and Janssen Canada. Speaker’s panel for Abbvie Canada, Janssen Canada, Pfizer Canada, and Takeda Canada. Received research funding from Abbvie Canada, Takeda Canada, Sandoz Canada, Amgen Canada, and Pfizer Canada.